Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 4,124 shares at $113.78 ($462K) on 2018-11-29, disclosed to the SEC on 2018-11-29.
Open-market sale of $462k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.66 | 1,438 | $156K | 33.8% |
| 2 | $113.78 | 1,343 | $153K | 33.1% |
| 3 | $113.78 | 1,343 | $153K | 33.1% |
| Total | $111.99 avg | 4,124 | $462K | 100% |
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |